Medical Director Articles

The term "article" is used to describe any bulletin article, web site article, educational handout or any other non-LCD document intended for public release that contains coverage/coding statements or medical review related billing or claims considerations.

Articles address local coverage, coding or medical review related billing and claims considerations, and may include any newly developed educational materials, coding instructions or clarification of existing medical review related billing or claims policy.

The article listing will continue to expand as additions are made.

Last Updated Jan 30 , 2024
Articles Source Posted
LCD Transurethral Waterjet Ablation of the Prostate - Effective December 14, 2025 Oct 30, 2025
Nerve Blockade for Treatment of Chronic Pain and Neuropathy L35457 - R19 - Effective 12/01/2019 Oct 30, 2025
Chest X-Ray L37549 - R5 - Effective November 01, 2019 Oct 30, 2025
Billing and Coding: Botulinum Toxins Type A and B (A57186) - R10 - Effective October 1, 2025 Oct 30, 2025
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58726) - R30 - Effective October 1, 2025 Oct 30, 2025
Billing and Coding: Total Knee Arthroplasty (A57686)- R2 - Effective December 1, 2019 Oct 23, 2025
ICD-10 Billing and Coding Article Updates - Effective October 1, 2025 Oct 23, 2025
Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumors (A58456) - R14 - Effective October 1, 2025 Oct 23, 2025
Billing and Coding: Cataract Surgery in Adults (A57195) - R9 - Effective October 1, 2025 Oct 23, 2025
Billing and Coding: MolDX: Melanoma Risk Stratification Molecular Testing (A57290) - R4 - Effective October 1, 2025 Oct 23, 2025
Billing and Coding: MolDX: Proteomics Testing (A59642) - R11 - Effective October 1, 2025 Oct 23, 2025
Billing and Coding: MolDX: Repeat Germline Testing (A57332) - R18 - Effective October 1, 2025 Oct 23, 2025
Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) (A57527) - R25 - Effective October 1, 2025 Oct 23, 2025
Multiple LCDs and Billing and Coding Articles Retirement - Effective October 23, 2025 Oct 23, 2025
Billing and Coding: Zika Virus Testing by PCR and ELISA Methods (A55327) - R12 - Effective October 01, 2022 Oct 16, 2025
MolDX: DecisionDx-UM (Uveal Melanoma) (L37072) - R7 - Effective June 30, 2022 Oct 16, 2025
MolDX: Prometheus IBD sgi Diagnostic Policy (L37313) - R9 - Effective March 13, 2025 Oct 16, 2025
MDS FISH (L37622) - R6 - Effective June 30, 2022 Oct 16, 2025
MolDX: Melanoma Risk Stratification Molecular Testing (L37748) - R8 - Effective June 26, 2025 Oct 16, 2025
Multiple LCDs and Billing and Coding Articles Retirement - Effective October 16, 2025 Oct 16, 2025
Billing and Coding: Routine Foot Care (A57957) - R16 - Effective October 1, 2025 Oct 16, 2025
Minimally Invasive Arthrodesis of the Sacroiliac Joint (SIJ) (L39812) - R2 - Effective April 17, 2025 Oct 09, 2025
ProMark Risk Score (L36706) - R6 - Effective December 30, 2021 Oct 09, 2025
MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms (L39927) - R2 - Effective August 17, 2025 Oct 09, 2025
MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (L39003) - R5 - Effective July 3, 2025 Oct 09, 2025
MolDX: Molecular Diagnostic Tests (MDT) (L36256) - R16 - Effective May 5, 2025 Oct 09, 2025
MolDX: NRAS Genetic Testing (L36339) - R8 - Effective July 23, 2023 Oct 09, 2025
MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma (L39594) - R8 - Effective August 18, 2024 Oct 09, 2025
MolDX: Minimal Residual Disease Testing for Cancer (L38816) - R1 - Effective January 2, 2022 Oct 09, 2025
Policy Revision(s) for Local Coverage Determinations and Associated Billing and Coding Articles - Effective Multiple Dates Oct 02, 2025
BDX-XL2 (L37062) - R4 - Effective April 28, 2022 Oct 02, 2025
MolDX: Pharmacogenomics Testing (L38337) - R3 - Effective October 2, 2025 Oct 02, 2025
Billing and Coding: MolDX: Pharmacogenomics Testing (A57385) - R17 - Effective July 3, 2025 Oct 02, 2025
Billing and Coding: MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) (A57424) - R5 - Effective November 7, 2024 Oct 02, 2025
Billing and Coding: MolDX: MGMT Promoter Methylation Analysis (A57433) - R3 - Effective October 14, 2021 Oct 02, 2025
Billing and Coding: MolDX: Oncotype DX Breast Cancer Assay (A54482) - R5 - Effective November 1, 2019 Oct 02, 2025
Multiple Billing and Coding Articles Retirement - Effective October 2, 2025 Oct 02, 2025
Billing and Coding: Implantable Infusion Pumps for Chronic Pain (A55323) - R22 - Effective October 1, 2025 Oct 02, 2025
2025 ICD-10 Billing and Coding Article Updates - Effective October 1, 2025 Oct 02, 2025
Self-Administered Drug Exclusion List (A53033) - R44 - Effective November 15, 2025 Oct 02, 2025
CORRECTED Billing and Coding: MolDX: Prometheus IBD sgi Diagnostic Policy (A57517) - R4 - Effective October 20, 2022 Sep 29, 2025
Multi-Jurisdictional Contractor Advisory Committee (CAC) Meeting Announcement - Implantation of Anterior Segment Intraocular Nonbiodegradable Drug-eluting System - November 12, 2025, 2 - 4 pm CT Sep 26, 2025
Billing and Coding: MolDX: MammaPrint (A54447) - R9 - Effective January 1, 2022 Sep 25, 2025
Billing and Coding: MolDX: Breast Cancer Index (BCI) Gene Expression Test (A57774) - R4 - Effective October 9, 2021 Sep 25, 2025
Billing and Coding: MolDX: FDA-Approved KRAS Tests (A54500) - R9 - Effective July 14, 2022 Sep 25, 2025
Billing and Coding: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease (A57236) - R5 - Effective January 1, 2021 Sep 25, 2025
Billing and Coding: BDX-XL2 (A57357) - R5 - Effective April 28, 2022 Sep 25, 2025
Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors (A58975) - R10 - Effective July 1, 2025 Sep 25, 2025
Billing and Coding: MolDX: Prometheus IBD sgi Diagnostic Policy (A57517) - R4 - Effective October 20, 2022 Sep 25, 2025
Peripheral Nerve Stimulation (L37360) - R5 - Effective December 1, 2019 Sep 25, 2025